ASKG-915

N/A

Report date: 2026/02/03 10:45:28

Base Information

Drug NameASKG-915
Drug Alias NameASKG-915
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed cell death protein 1 blockersInterleukin-15 receptor subunit alpha agonists
TargetsProgrammed cell death protein 1Interleukin-15 receptor subunit alpha
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAskgene Pharma
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Aosaikang Biomedical Co LtdAskGene Pharma IncAskgene Pharma +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A